UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evaluation of Tumor Response, Disease Control, Progression-Free Survival, and Time to Progression As Potential Surrogate End Points in Metastatic Breast Cancer

Journal of clinical oncology, 2008-04, Vol.26 (12), p.1987-1992

2008

Volltextzugriff (PDF)

Taxanes Alone or in Combination With Anthracyclines As First-Line Therapy of Patients With Metastatic Breast Cancer

Journal of clinical oncology, 2008-04, Vol.26 (12), p.1980-1986

2008

Volltextzugriff (PDF)

Docetaxel and Doxorubicin Compared With Doxorubicin and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer: Results of a Randomized, Multicenter, Phase III Trial

Journal of clinical oncology, 2003-03, Vol.21 (6), p.968-975

2003

Volltextzugriff (PDF)

Docetaxel-anthracycline combinations in metastatic breast cancer

Breast cancer research and treatment, 2003-01, Vol.79 (S1), p.S3-S9

NABHOLTZ, Jean-Marc A

2003

Volltextzugriff (PDF)

Docetaxel in the treatment of breast cancer: An update on recent studies

Seminars in oncology, 2002-06, Vol.29 (3), p.28-34

2002

Volltextzugriff (PDF)

Growth Factors and Cytokines Upregulate Gelatinase Expression in Bone Marrow CD34+ Cells and Their Transmigration Through Reconstituted Basement Membrane

Blood, 1999-05, Vol.93 (10), p.3379-3390

1999

Volltextzugriff (PDF)

Third-generation aromatase inhibitors in the treatment of advanced breast cancer

Breast cancer (Tokyo, Japan), 2001-10, Vol.8 (4), p.305-309

2001

Volltextzugriff (PDF)

Docetaxel/trastuzumab combination therapy for the treatment of breast cancer

Expert opinion on pharmacotherapy, 2005-08, Vol.6 (9), p.1555-1564

2005

Volltextzugriff (PDF)

Docetaxel in the treatment of breast cancer: current experience and future prospects

Expert review of anticancer therapy, 2005-08, Vol.5 (4), p.613-633

2005

Volltextzugriff (PDF)

HER2-Positive Breast Cancer: Update on Breast Cancer International Research Group Trials

Clinical breast cancer, 2002-10, Vol.3, p.S75-S79

2002

Volltextzugriff (PDF)

New adjuvant strategies for breast cancer: Meeting the challenge of integrating chemotherapy and trastuzumab (Herceptin)

Seminars in oncology, 2001-02, Vol.28 (1 Suppl 3), p.1-12

2001

Volltextzugriff (PDF)

The Choice of Adjuvant Combination Therapies with Taxanes: Rationale and Issues Addressed in Ongoing Studies

Clinical breast cancer, 2001-10, Vol.2, p.S7-S14

2001

Volltextzugriff (PDF)

Phase III Trial Comparing Granulocyte Colony-Stimulating Factor to Leridistim in the Prevention of Neutropenic Complications in Breast Cancer Patients Treated with Docetaxel/Doxorubicin/Cyclophosphamide: Results of the BCIRG 004 Trial

Clinical breast cancer, 2002-10, Vol.3 (4), p.268-275

2002

Volltextzugriff (PDF)

1 – 14 von 14

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieBulletin Du Cancer

ThemaAntineoplastic Combined Chemotherapy Protocols - Therapeutic Use

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(14)

Sprache

Englisch
(14)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breast 3): a randomised, open-label, multicentre, phase 2 trial

Evaluation of Tumor Response, Disease Control, Progression-Free Survival, and Time to Progression As Potential Surrogate End Points in Metastatic Breast Cancer

Taxanes Alone or in Combination With Anthracyclines As First-Line Therapy of Patients With Metastatic Breast Cancer

Docetaxel and Doxorubicin Compared With Doxorubicin and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer: Results of a Randomized, Multicenter, Phase III Trial

Docetaxel-anthracycline combinations in metastatic breast cancer

Docetaxel in the treatment of breast cancer: An update on recent studies

Growth Factors and Cytokines Upregulate Gelatinase Expression in Bone Marrow CD34+ Cells and Their Transmigration Through Reconstituted Basement Membrane

Third-generation aromatase inhibitors in the treatment of advanced breast cancer

Docetaxel/trastuzumab combination therapy for the treatment of breast cancer

Docetaxel in the treatment of breast cancer: current experience and future prospects

HER2-Positive Breast Cancer: Update on Breast Cancer International Research Group Trials

New adjuvant strategies for breast cancer: Meeting the challenge of integrating chemotherapy and trastuzumab (Herceptin)

The Choice of Adjuvant Combination Therapies with Taxanes: Rationale and Issues Addressed in Ongoing Studies

Phase III Trial Comparing Granulocyte Colony-Stimulating Factor to Leridistim in the Prevention of Neutropenic Complications in Breast Cancer Patients Treated with Docetaxel/Doxorubicin/Cyclophosphamide: Results of the BCIRG 004 Trial

Aktive Filter

Suchergebnisse filtern